Editorial: Steroid hormone receptors and cell cycle in breast cancer | ||
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Massachusetts General Hospital | |
| dc.conicet.organizacion | Universidade de Aveiro | |
| dc.contributor.author | Fabris, Victoria Teresa | |
| dc.contributor.author | Spring Laura | |
| dc.contributor.author | Helguero, Luisa Alejandra | |
| dc.date.issued | 2023-04-12 | |
| dc.description.abstract | Breast cancer is the most frequently diagnosed cancer in women with a high incidence and mortality worldwide. Nearly 70% of breast carcinomas express steroid hormone receptors and therefore patients can be treated with endocrine therapy. The treatment is principally targeted to block the estrogen receptor (ER) or estrogen synthesis (1). However, increasing evidence also suggests that the progesterone receptor (PR) is a potential target for therapy (2). | es |
| dc.description.fil | Fil: Fabris, Victoria Teresa. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina | |
| dc.description.fil | Fil: Spring Laura. Harvard Medical School; Estados Unidos. Massachusetts General Hospital; Estados Unidos | |
| dc.description.fil | Fil: Helguero, Luisa Alejandra. Universidade de Aveiro; Portugal | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Fabris, Victoria Teresa; Spring Laura; Helguero, Luisa Alejandra; Editorial: Steroid hormone receptors and cell cycle in breast cancer; Frontiers Media; Frontiers in Endocrinology; 14; 1196523; 12-4-2023; 1-3 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1664-2392 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/238246 | |
| dc.journal.ciudad | Lausana | es |
| dc.journal.number | 1196523 | es |
| dc.journal.pagination | 1-3 | es |
| dc.journal.pais | Suiza | es |
| dc.journal.title | Frontiers in Endocrinology | es |
| dc.journal.volume | 14 | es |
| dc.language.iso | eng | es |
| dc.publisher | Frontiers Media | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3389/fendo.2023.1196523 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1196523/full | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by/2.5/ar/ | * |
| dc.subject | BREAST CANCER | es |
| dc.subject | HORMONE RECEPTORS | es |
| dc.subject | ENDOCRINE RESISTANCE | es |
| dc.subject | CELL CYLCE INHIBITORS | es |
| dc.subject | CROSSTALK | es |
| dc.subject.classification | Oncología | es |
| dc.subject.classification | Medicina Clínica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Editorial: Steroid hormone receptors and cell cycle in breast cancer | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.5251ef3b-c95e-4c6c-95e4-7b2d1ebb1d23_B.pdf
- Tamaño:
- 298.26 KB
- Formato:
- Adobe Portable Document Format